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Abstract 
The Comparative Toxicogenomics Database (CTD) is a free resource that describes chemical-gene-disease networks to help 
understand the effects of environmental exposures on human health.  The database contains more than 13,500 chemical-disease and 
14,200 gene-disease interactions.  In CTD, chemicals and genes are associated with a disease via two types of relationships: as a 
biomarker or molecular mechanism for the disease (M-type) or as a real or putative therapy for the disease (T-type).  We leveraged 
these curated datasets to compute similarity indices that can be used to produce lists of comparable diseases (“DiseaseComps”) 
based upon shared toxicogenomic profiles.  This new metric now classifies diseases with common molecular characteristics, instead 
of the traditional approach of using histology or tissue of origin to define the disorder. In the dawning era of “personalized 
medicine”, this feature provides a new way to view and describe diseases and will help develop testable hypotheses about 
chemical-gene-disease networks. 
 
Availability: CTD is freely available at http://ctd.mdibl.org/ 
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Background: 
The Comparative Toxicogenomics Database (CTD) is a public 
resource that promotes understanding about the effects of 
environmental chemicals on human health [1].  CTD 
biocurators manually curate interactions from the scientific 
literature in a structured format using controlled vocabularies 
for chemicals, genes, diseases, molecular interactions, and 
organisms  [2].  These datasets can be used to explore 
relationships and to generate novel, testable hypotheses about 
chemical-gene-disease pathways. 
 
Analyses of the human disease network strive to categorize 
diseases with respect to common genes and molecular 
pathways, enabling hypotheses about shared or predisposing 
co-disorders and putative genetic susceptibilities [3]. Disease 
names, especially cancers, were often originally based upon 
histology (e.g., carcinoma) or tissue of origin (e.g., liver cancer).  
With the advent of molecular genotyping, however, many 
cancers are now being further differentiated by their unique 
molecular signatures (e.g., HER2-positive vs. HER2-negative 
breast cancer). Bioinformatics analyses of human disease 
networks have also discovered sets of interacting proteins and 
molecular pathways often shared by multiple diseases [4]. This 
shift to analyzing, classifying, and describing diseases via their 
molecular perspective can help discover new therapeutic 
approaches not previously considered.  For example, shared 
molecular connections between diabetes and dementia are now 
fueling research into the possible use of insulin to treat 
Alzheimer disease [5]. 
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Personalized medicine (which seeks to improve a drug’s 
therapeutic potential as well as minimize its side-effects) is 
dependent upon understanding the unique molecular profile of 
the patient and their disease [6].  Genes alone, however, are not 
solely responsible for all complex diseases, since the 
environment also plays an important role [7].  T h u s ,  C T D ,  
which integrates datasets for all three components of 
environmental chemicals, genes, and diseases, can be uniquely 
leveraged to further advance hypotheses on human disorders.  
Discovering analogous diseases (based upon their shared 
toxicogenomic portrait) could promote alternative methods for 
classifying diseases beyond the standard histological 
techniques, and more towards a molecular basis. 
 
Here we report a new bioinformatics approach to discovering 
analogous diseases based upon shared chemical and/or gene 
relationship profiles in CTD, which we call DiseaseComps (for 
comparable diseases). This metric parallels our previous 
implementation of GeneComps and ChemComps, which 
organized analogous genes and chemicals, respectively, based 
upon common toxicogenomic interactions [8].   
 
 
Figure 1:  (a) DiseaseComps (orange tab) for schizophrenia via 
gene marker/mechanism (M-type) relationships include 
familiar diseases such as bipolar disorder, autism, and 
psychoses (ranked #1-3), but also discovers non-intuitive 
diseases like breast cancer (ranked #6) that share ten M-type 
genes with schizophrenia (red circle).  (b) The common curated 
genes can be viewed by clicking on the hyperlinked numeral 
(red circle) to produce a Venn diagram and a list of the ten 
genes shared between schizophrenia and breast cancer. 
 
Methodology: 
CTD biocurators manually curate the literature to capture 
chemical-disease and gene-disease relationships [2].  A chemical 
or gene can have an M-type relationship (wherein the molecule 
acts as either a biomarker or plays a role in the molecular 
mechanism of the disease) or a T-type relationship (wherein the 
molecule is described as either a real or putative therapeutic for 
the disease).  Here we used the data available in CTD in 
September 2011, which included 13,530 chemical-disease 
relationships (for 2,652 chemicals and 1,180 diseases) and 14,173 
gene-disease relationships (for 5,470 genes and 4,149 diseases).  
Similarity indices were computed using a modification of the 
Jaccard index, whose value ranges between 0 and 1 [8].  
DiseaseComps are delineated by the type of relationship (M or 
T-type).  For example, chemicals with a T-type relationship to a 
disease can be used to find comparable diseases wherein the 
chemicals have the same T-type relationship. Six types of 
DiseaseComps are generated: (1) via all chemical relationships 
(M- and T-type combined), (2) via only chemical M-type 
relationships, (3) via only chemical T-type relationships, (4) via 
all gene relationships (M- and T-type combined), (5) via only 
gene M-type relationships, and (6) via only gene T-type 
relationships. 
 
Utility: 
CTD computes values that reflect the degree of similarity 
between the molecular interaction profiles of each curated 
disease and generates a list of DiseaseComps, delineated by the 
six possible types of relationships.  DiseaseComps provide a 
simple approach to view diseases that share common molecular 
interactions, allowing disorders to be classified in a novel 
manner without regard to histology or tissue of origin.  Every 
curated disease in CTD now includes a DiseaseComps data tab 
that lists the top 20 comparable diseases based upon their 
ranked similarity index. For example, the disease schizophrenia 
has 160 genes curated with an M-type relationship in CTD.   
DiseaseComps identifies the top comparable diseases for 
schizophrenia that share the greatest number of those 160 M-
type genes to produce a ranked list that includes bipolar 
disorder, autism, and psychoses, as well as non-intuitive 
diseases such as breast, lung, and colorectal cancers (Figure 1a), 
suggesting that schizophrenia shares many of the same 
molecular networks common to some cancers.  The shared 
genes can be viewed by clicking on the hyperlinked numeral in 
the “Common Interacting Gene” column (Figure 1b).  This new 
CTD metric provides researchers with additional predictive 
information that can help construct novel, testable hypotheses 
about the mechanisms (and potentially treatments or targets) 
underlying schizophrenia based upon its shared molecular 
profile with other diseases. 
 
Future development: 
DiseaseComps find similar diseases based upon shared 
chemical or gene relationships.  The algorithm can be reversed 
to now find similar genes (or chemicals) based upon shared 
diseases, a feature we hope to soon add to our already 
established GeneComps and ChemComps data-tabs at CTD [8].  
CTD is also expanding its content via the targeted curation of 
over 50,000 additional toxicology publications selected for four 
disease areas (cardiovascular, renal, hepatic, and neurological 
disorders). This will provide significantly more data as input 
for the generation of DiseaseComps calculations. 
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